Skip to main content

CHAMPIONS ONCOLOGY, INC.

For the period ended Aug 27, 2026. Filed Aug 28, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Aug 27, 2026 · Filed Aug 28, 2026

CSBR$4.79+0.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Summary Compensation Table

The following table sets forth information regarding the total compensation paid or earned by the named executive officers as compensation for their services in all capacities during the fiscal years ended April 30, 2026 and 2025.

Name and PrincipalPositionYearBaseSalary($)Bonus($)StockAwards ($)OptionAwards ($)(1)All OtherCompensationTotal ($)
Robert Brainin (2)2026346,154——3,220,868—3,567,022
Chief Executive Officer2025——————
Ronnie Morris (3)2026233,333————233,333
Chief Executive Officer2025400,000200,000———600,000
David Miller (4)2026315,00025,000—48,464—388,464
Chief Financial Officer2025278,33325,000—7,444—310,777
Brady Davis (5)2026——————
President2025177,083————177,083

(1)The amounts shown in the “Option Awards” column reflect the grant date value of the stock option awards computed in accordance with Financial Accounting Standards Board ASC Topic 718. For a discussion of valuation assumptions, see note 8 to the financial statements in the Company's Form 10-K filed on July 27, 2026. While these amounts are deductible for federal income tax purposes, for financial statement purposes these amounts are charged to additional paid-in capital.

(2) Base salary in 2026 has an effective start date of August 25, 2025 for current base salary of $500,000 annually.

(3) Base salary in 2026 reflects compensation paid on base salary of $500,000 annually.

(4) Base salary in 2025 is comprised of current base salary of $315,000 and previous salary of $260,000 to reflect base salary paid for the fiscal year ended April 30, 2025.

(5) Base salary represents prorated amount for fiscal year 2025 from May 1, 2024 through Oct 2024 due to Mr. Davis's death.

The Compensation Committee has the right to change and increase the compensation of executive officers at any time.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.